North Peak Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-138,991
Closed -$48.7M 8
2025
Q4
$48.7M Sell
138,991
-113,818
-45% -$38.5M 4.14% 8
2025
Q3
$81.7M Sell
252,809
-148,861
-37% -$46.3M 7.16% 6
2025
Q2
$156M Buy
401,670
+115,460
+40% +$46.4M 12.27% 4
2025
Q1
$124M Buy
286,210
+91,596
+47% +$36.8M 12.5% 4
2024
Q4
$71.8M Buy
+194,614
New +$81.4M 9.51% 6

Other funds holding ELV

North Peak Capital Management's ELV Position: Q1 2026 in Review

North Peak Capital Management sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 138,991 shares — an estimated $48.7M sold.

North Peak Capital Management first reported a position in ELV in Q4 2024 and held it in 5 quarters. The position peaked at $156M in Q2 2025. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • North Peak Capital Management reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • North Peak Capital Management sold 138,991 Elevance Health shares in Q1 2026, an estimated $48.7M.
  • North Peak Capital Management first reported a position in Elevance Health in Q4 2024 and held it in 5 quarters.
  • North Peak Capital Management's Elevance Health position peaked at $156M in Q2 2025.
  • 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on North Peak Capital Management's 13F filing for Q1 2026, filed 14 May 2026.